Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 9, 2001New England Journal of Medicine

The Coxibs, Selective Inhibitors of Cyclooxygenase-2

View Full Paper
Ask AI
Bookmark
Share

Authors

Garret A. FitzGerald
Garret A. FitzGeraldPreventive Cardiology
Carlo Patrono
Carlo PatronoPreventive Cardiology

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

FitzGerald et al. (2001) studied this question.

synapsesocial.com/papers/6a03464cdaa0ebdf9f9e57a9https://doi.org/10.1056/nejm200108093450607
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 14-[5-Methyl-3-phenylisoxazol-4-yl]- benzenesulfonamide, Valdecoxib:  A Potent and Selective Inhibitor of COX-22000 · 642 citations
  2. 2Transforming Growth Factor-β1 Enhances Ha-ras-induced Expression of Cyclooxygenase-2 in Intestinal Epithelial Cells via Stabilization of mRNA2000 · 197 citations
  3. 3Acceleration of atherogenesis by COX-1-dependent prostanoid formation in low density lipoprotein receptor knockout mice2001 · 216 citations
  4. 4Oxidative Damage of Cardiomyocytes Is Limited by Extracellular Regulated Kinases 1/2-mediated Induction of Cyclooxygenase-21999 · 376 citations
  5. 5Is cyclooxygenase-2 the alpha and the omega in cancer?2000 · 100 citations